SCHEMBL5149384

SCHEMBL5149384

N#Cc1ccccc1OCCCCOc1ccc2c3ccccc3n(CCC(=O)O)c2c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 11/20 0.50
PSEN2 P49810 11/20 0.50
APH1B Q8WW43 11/20 0.50
NCSTN Q92542 11/20 0.50
APH1A Q96BI3 11/20 0.50
PSENEN Q9NZ42 11/20 0.50
FABP4 P15090 3/20 0.50
FABP5 Q01469 3/20 0.50
FABP3 P05413 1/20 0.50
MCL1 Q07820 1/20 0.49
PLA2G2A P14555 2/20 0.42
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5156137 0.89 PSEN1 (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5154757 0.88 KDM4E (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5152501 0.88 FABP4 (0.54) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5151535 0.85 FABP4 (0.62) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5155933 0.85 FABP4 (0.53) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5152552 0.85 PSEN1 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5152361 0.85 PSEN1 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5151743 0.85 FABP4 (0.53) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5149618 0.83 FABP4 (0.57) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5152037 0.83 FABP4 (0.51) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US claimed
WO-2007071456-A1 FLUORENES AND CARBAZOLES AS LIGANDS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-28 WO claimed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor PTGER2, PTGER1, PTGDR2 PSEN1 2971/4885PSEN2 1240/4885APH1B 3232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.